Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Pioglitazone on Insulin Signaling in Skeletal Muscle
NCT03452267Phase 3
Key facts
- Status
- Withdrawn
- Start
- Sep 2019
- Primary completion
- Dec 2024
- Sponsor
- Wayne State University
- Modality
- Small Molecules
- Conditions
- prediabetes
01
Overview
Phase 3, randomised, double-blind trial of liquid metformin (Aspargo Labs) and pioglitazone in prediabetes, sponsored by Wayne State University. Planned start Sep 2019; status: withdrawn.
02
Design
- Study design
- RandomizedDouble-blind
03
Registry description
The insulin sensitizing effects of metformin and pioglitazone in the skeletal muscle remain unknown. Our group aims to analyze molecular changes within the skeletal muscle of pre-diabetic patients through the use of a clinical trial in humans.
Beyond the preview
Go deeper on NCT03452267.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03452267.